Stockholm - Delayed Quote SEK

Zenicor Medical Systems AB (ZENI.ST)

2.7000
+0.1000
+(3.85%)
At close: May 21 at 5:05:20 PM GMT+2
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,579.9520
25,211.9620
24,157.2740
21,480.7310
19,659.2030
Cost of Revenue
-2,340.2670
-2,841.6810
-4,153.7560
-2,801.8080
-1,149.2290
Gross Profit
27,920.2190
28,053.6430
28,311.0300
24,282.5390
20,808.4320
Operating Expense
26,551.6350
27,927.5980
32,422.0790
25,047.8390
19,594.7750
Operating Income
1,368.5840
126.0450
-4,111.0490
-765.3000
1,213.6570
Net Non Operating Interest Income Expense
-2,454.8120
-2,301.5280
-1,613.5480
-1,112.5830
-632.1550
Pretax Income
-994.8820
-2,084.1370
-5,587.7130
-1,747.2560
628.8230
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-994.8820
-2,084.1370
-5,587.7130
-1,747.2560
628.8230
Diluted NI Available to Com Stockholders
-994.8820
-2,084.1370
-5,587.7130
-1,747.2560
628.8230
Basic EPS
-0.11
--
-0.62
-0.11
0.10
Diluted EPS
-0.11
--
-0.62
-0.11
0.10
Basic Average Shares
9,022.7890
--
9,022.7890
6,413.5180
6,413.5180
Diluted Average Shares
9,022.7890
--
9,022.7890
6,413.5180
6,413.5180
Total Operating Income as Reported
1,459.9300
217.3910
-3,974.1650
-634.6730
1,260.9780
Total Expenses
24,211.3680
25,085.9170
28,268.3230
22,246.0310
18,445.5460
Net Income from Continuing & Discontinued Operation
-994.8820
-2,084.1370
-5,587.7130
-1,747.2560
628.8230
Normalized Income
-994.8820
-2,084.1370
-5,587.7130
-1,747.2560
628.8230
Interest Income
6.3680
6.3680
23.9200
0.0530
--
Interest Expense
2,461.1800
2,307.8960
1,637.4680
1,112.6360
632.1550
Net Interest Income
-2,454.8120
-2,301.5280
-1,613.5480
-1,112.5830
-632.1550
EBIT
1,466.2980
223.7590
-3,950.2450
-634.6200
1,260.9780
EBITDA
5,617.3590
4,460.4100
-852.4060
92.8970
1,290.2390
Reconciled Cost of Revenue
-2,340.2670
-2,841.6810
-4,153.7560
-2,801.8080
-1,149.2290
Reconciled Depreciation
4,151.0610
4,236.6510
3,097.8390
727.5170
29.2610
Net Income from Continuing Operation Net Minority Interest
-994.8820
-2,084.1370
-5,587.7130
-1,747.2560
628.8230
Normalized EBITDA
5,617.3590
4,460.4100
-852.4060
92.8970
1,290.2390
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/18/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers